[go: up one dir, main page]

NO20055694L - Fremgangsmate for fremstilling av (4-hydroksy-6-oksotetrahydropyran-2-yl)acetonitril og derivater derav - Google Patents

Fremgangsmate for fremstilling av (4-hydroksy-6-oksotetrahydropyran-2-yl)acetonitril og derivater derav

Info

Publication number
NO20055694L
NO20055694L NO20055694A NO20055694A NO20055694L NO 20055694 L NO20055694 L NO 20055694L NO 20055694 A NO20055694 A NO 20055694A NO 20055694 A NO20055694 A NO 20055694A NO 20055694 L NO20055694 L NO 20055694L
Authority
NO
Norway
Prior art keywords
hydroxy
acetonitrile
preparation
pyran
tetrahydro
Prior art date
Application number
NO20055694A
Other languages
English (en)
Other versions
NO20055694D0 (no
Inventor
Wilhelmus Hubertus Jos Boesten
Daniel Mink
Michael Wolberg
Natascha Sereinig
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Publication of NO20055694D0 publication Critical patent/NO20055694D0/no
Publication of NO20055694L publication Critical patent/NO20055694L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Epoxy Compounds (AREA)

Abstract

Oppfmnelsen vedrører en fremgangsmåte for fremstilling av (4-hydroksy-6-okso-tefrahydro- pyran-2-yl)-acetonitril fra 6-X-substituert-metyl-4-hydroksy-tefrahydro-pyran-2-on, hvori X står for en forlatende gruppe, ved å reagere 6-Xsubstituert-metyl-4-hydroksy-tefrahydro-pyran-2-on med et cyanidion i vann og ved påfølgende senking av pHen til en pH mellom 0 og 5. (4-Hydroksy-6-okso- tefrahydro-pyran-2-yl)-acetonitril og andre forbindelser som kan oppnås fra (4-hydroksy-6-okso- tefrahydro-pyran-2-yl)-acetonitril kan egnet anvendes i fremstillingen av et farmasøytisk preparat, mer spesielt i fremstillingen av statiner, mer spesielt i fremstillingen av Atorvastatine eller et salt derav, for eksempel dets kalsiimisalt. Oppfirmelsen vedrører også (4-hydroksy-6-okso-tetrahydro-pyran-2-yl)- acetonitril og andre forbindelser som kan oppnås derfra.
NO20055694A 2003-05-02 2005-12-01 Fremgangsmate for fremstilling av (4-hydroksy-6-oksotetrahydropyran-2-yl)acetonitril og derivater derav NO20055694L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03101227 2003-05-02
PCT/NL2004/000284 WO2004096788A1 (en) 2003-05-02 2004-04-28 Process fot the preparation of (4-hydroxy-6-oxo-tetrahydropyran-2-yl) acetonitrile and derivatives thereof

Publications (2)

Publication Number Publication Date
NO20055694D0 NO20055694D0 (no) 2005-12-01
NO20055694L true NO20055694L (no) 2006-02-02

Family

ID=33395971

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055694A NO20055694L (no) 2003-05-02 2005-12-01 Fremgangsmate for fremstilling av (4-hydroksy-6-oksotetrahydropyran-2-yl)acetonitril og derivater derav

Country Status (24)

Country Link
US (1) US7423162B2 (no)
EP (1) EP1620423B1 (no)
JP (1) JP2006525323A (no)
KR (1) KR20060011984A (no)
CN (2) CN101775000B (no)
AT (1) ATE386734T1 (no)
AU (1) AU2004234308A1 (no)
BR (1) BRPI0409866A (no)
CA (1) CA2524457A1 (no)
CO (1) CO5700715A2 (no)
CY (1) CY1113498T1 (no)
DE (1) DE602004011921T2 (no)
DK (1) DK1620423T3 (no)
EA (1) EA010100B1 (no)
ES (1) ES2300769T3 (no)
IL (1) IL171539A (no)
IS (1) IS8159A (no)
NO (1) NO20055694L (no)
NZ (1) NZ543294A (no)
PL (1) PL1620423T3 (no)
SI (1) SI1620423T1 (no)
UA (1) UA83662C2 (no)
WO (1) WO2004096788A1 (no)
ZA (1) ZA200508862B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2522656A3 (en) 2003-07-25 2013-03-20 Redx Pharma Limited Process and Intermediate Compounds Useful in the Preparation of Statins, Particularly Atorvastatin
US7701550B2 (en) 2004-08-19 2010-04-20 Asml Netherlands B.V. Lithographic apparatus and device manufacturing method
DE102005022284A1 (de) * 2005-05-13 2006-11-23 Ratiopharm Gmbh Verfahren zur Herstellung von Statinen
US8047545B2 (en) * 2007-11-07 2011-11-01 Douglas Press, Inc. Lottery-type game with rollover feature
US8404870B2 (en) * 2008-01-23 2013-03-26 Lek Pharmaceuticals D.D. ((2S,4R)-4,6-dihydroxytetrahydro-2H-pyran-2-yl)methyl carboxylate and process for the production thereof
EP2614057B1 (en) * 2010-09-09 2015-10-21 DSM Sinochem Pharmaceuticals Netherlands B.V. Salts of 7-amino-3,5-dihydroxyheptanoic acid esters
MX2013002809A (es) * 2010-09-16 2013-04-29 Dsm Sinochem Pharm Nl Bv Esteres de acidos hexanoicos.
CN105669637A (zh) * 2014-11-21 2016-06-15 南京博优康远生物医药科技有限公司 一种3,5,6-取代己酸酯衍生物的制备方法
CN112501223B (zh) * 2020-11-23 2022-08-12 江苏阿尔法药业股份有限公司 制备2-((2r，4r)-4-羟基-6-氧代四氢-2h-吡喃-2-基)乙腈的方法
CN116102482A (zh) * 2022-08-17 2023-05-12 重庆普佑生物医药有限公司 一种阿托伐他汀钙的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5097045A (en) * 1989-02-01 1992-03-17 Warner-Lambert Company Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis
US5003080A (en) * 1988-02-22 1991-03-26 Warner-Lambert Company Process for trans-6-(2-(substituted-pyrrol-1-yl)alkyl)pryan-2-one inhibitors of cholesterol synthesis
NL1015744C2 (nl) * 2000-07-19 2002-01-22 Dsm Nv Werkwijze voor de bereiding van 2-(6-gesubstitueerde-1,3-dioxan-4-yl) azijnzuurderivaten.
US7414119B2 (en) * 2002-09-20 2008-08-19 Verenium Corporation Aldolases, nucleic acids encoding them and methods for making and using them

Also Published As

Publication number Publication date
IS8159A (is) 2005-11-30
CN1780826A (zh) 2006-05-31
US20060258733A1 (en) 2006-11-16
ATE386734T1 (de) 2008-03-15
JP2006525323A (ja) 2006-11-09
ES2300769T3 (es) 2008-06-16
NO20055694D0 (no) 2005-12-01
ZA200508862B (en) 2007-02-28
NZ543294A (en) 2008-05-30
CN101775000B (zh) 2014-09-24
IL171539A (en) 2011-03-31
CN1780826B (zh) 2010-05-26
CA2524457A1 (en) 2004-11-11
BRPI0409866A (pt) 2006-05-16
EA010100B1 (ru) 2008-06-30
PL1620423T3 (pl) 2008-07-31
UA83662C2 (ru) 2008-08-11
EP1620423B1 (en) 2008-02-20
DE602004011921D1 (de) 2008-04-03
KR20060011984A (ko) 2006-02-06
AU2004234308A1 (en) 2004-11-11
EA200501734A1 (ru) 2006-04-28
CY1113498T1 (el) 2016-06-22
US7423162B2 (en) 2008-09-09
SI1620423T1 (sl) 2008-06-30
WO2004096788A1 (en) 2004-11-11
CN101775000A (zh) 2010-07-14
DK1620423T3 (da) 2008-05-26
DE602004011921T2 (de) 2009-02-19
EP1620423A1 (en) 2006-02-01
CO5700715A2 (es) 2006-11-30

Similar Documents

Publication Publication Date Title
NO20100062L (no) Overflatereagert kalsiumkarbonat i kombinasjon med hydrofob adsorbent for vannbehandling
EA201070001A1 (ru) Водная композиция, содержащая соль, способ её получения и применения
NO20083411L (no) Indaneddiksyrederivater og deres anvendelse som farmasoytiske midler, intermediater og fremgangsmater for fremstilling
CY1111327T1 (el) Υποκατεστημενα παραγωγα κυκλοεξυλοξεικου οξεος
NO20055694L (no) Fremgangsmate for fremstilling av (4-hydroksy-6-oksotetrahydropyran-2-yl)acetonitril og derivater derav
WO2006012395A3 (en) Peptidase inhibitors
NO20076000L (no) Aminosyrederivater
SE0200843D0 (sv) Chemical compounds
NO20082005L (no) Syntese av renininhibitorer omfattende en cyklotilfoyelsesreaksjon
NO20055750L (no) Nye kjemiske forbindelser
KR101632545B1 (ko) 황산 환원균의 선택적 제균방법, 상기 방법에 의해 황산 환원균의 증식을 억제하는 석고 조성물, 석고계 고화재 및 석고계 건재
NO20060718L (no) Substituerte tiofoner og deres anvendelse
WO2006066044A3 (en) Processes for producing 4-aminoquinazolines
EP1944027A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF NEPHRITIS AND METHOD OF MANUFACTURE THEREOF
GB0223223D0 (en) Organic compounds
GB0412865D0 (en) Chemical compounds
TW200722419A (en) Chemical compounds
NO20064410L (no) Fremgangsmate for fremstilling av tryptaseinhibitorer
IL158530A0 (en) Method for producing 1,3-disubstituted 2-nitroguanidines
TH79415A (th) กระบวนการสำหรับการเตรียมไพริมิดีนที่ถูกแทนที่
TW200616893A (en) Method for manufacturing aluminum salt solution, aluminum salt solution, aluminum salt, water purifying apparatus using the same, and articles manufactured by using the same
WO2007016209A3 (en) Pure 1,2-benzisoxazole-3-methane-sulfonic acid sodium salt and purification process
MXPA04004537A (es) Derivados de gabusectina, metodo para produccion de los mismos y uso de los mismos.
WO2007118325A8 (en) Enhancement of memory and/or cognition using substituted butyrophenone compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application